openPR Logo
Press release

Protheragen Announces GeniusAb Trademark : A Fully Human Single-Domain Antibody Platform

01-23-2025 11:28 PM CET | Health & Medicine

Press release from: Getnews

/ PR Agency: Release News - PR Distribution
Protheragen Announces GeniusAb Trademark : A Fully Human

New York, United States - Protheragen has launched GeniusAb Trademark [https://www.geniusab.com/], a fully human single-domain antibody platform to produce high quality and customized antibodies for research, diagnostic and therapeutic use. This is a major breakthrough in the field of therapeutic antibodies as it is able to provide highly specific, robust, and versatile solutions to a variety of diseases.

Single-domain antibodies (sdAbs), also known as VHH antibodies or camelid antibodies, are derived from the immune systems of camels and llamas. Unlike conventional antibodies, the unique structure of sdAbs allows them to bind to targets with high affinity and selectivity while maintaining stability and ease of production. These advantages make sdAbs a promising tool in biotechnology and therapeutics.

To reduce the costs and time involved in identifying new therapeutic single-domain antibodies from species such as camels and sharks, Protheragen has found a way to do so: the GeniusAb Trademark mice. These genetically engineered mice are designed to produce fully human single-domain antibodies. By leveraging these mice, researchers can avoid the need for in vitro humanization, leading to a more streamlined and economical process.

Protheragen's GeniusAb Trademark mouse model [https://www.geniusab.com/geniusab-fully-human-single-domain-antibody-platform.html] boasts several advantages, including:

- Robust immune responses to diverse antigens: The GeniusAb Trademark mouse models have a rich repertoire of B cells capable of recognizing and responding to different antigens, including proteins, peptides, and pathogens.

- Sequence diversity and optimal affinity: By incorporating human antibody gene segments and implementing genetic modifications, GeniusAb Trademark mice exhibit a variety of antibody sequences that closely mimic those present in humans, which can enable the examination of a wide array of antibody variants and enhance the likelihood of discovering antibodies with ideal affinity and specificity for the desired target.

- Excellent developability: Antibodies produced from GeniusAb Trademark mice possess advantageous traits, including stability, solubility, low immunogenicity, and compatibility with subsequent manufacturing processes, paving the way for the development and commercialization of antibody-based therapeutics and diagnostics.

The GeniusAb Trademark platform harnesses the unique properties of single-domain antibodies while ensuring that they are entirely compatible with the human immune system. This innovation opens new avenues for drug discovery and development, allowing researchers to tackle previously challenging targets with unmatched precision and efficacy.

About Protheragen

Protheragen GeniusAb Trademark focuses on fully human single-domain antibodies. Leveraging cutting-edge fully human single-domain antibody platforms and advanced antibody screening platforms, Protheragen offers comprehensive and seamless solutions for antibody preparation and screening.

Image: https://www.globalnewslines.com/uploads/2025/01/2957b4cb9bcedb33ef965d806175fb99.jpg
Media Contact
Company Name: Protheragen
Contact Person: Selina Green
Email: Send Email [http://www.universalpressrelease.com/?pr=protheragen-announces-geniusab-a-fully-human-singledomain-antibody-platform]
Country: United States
Website: https://www.protheragen.us/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Protheragen Announces GeniusAb Trademark : A Fully Human Single-Domain Antibody Platform here

News-ID: 3830819 • Views:

More Releases from Getnews

How One Chicago Moving Company Thrives on Tight Deadlines
How One Chicago Moving Company Thrives on Tight Deadlines
Chicago, IL - February 15, 2026 - While many moving companies demand one or two weeks of lead time, Coffey Bros. Moving [https://coffeybrosmoving.com/] has built its brand on the exact opposite: accepting the jobs that competitors reject. By specializing in same-day service and tight deadlines, the Chicago-based firm has secured a unique foothold in a crowded marketplace. Image: https://www.globalnewslines.com/uploads/2026/02/f25d7c8a3f9515e256a68f8af207b1c0.jpg "In this industry, the default response is often, 'Call us back in two
From California Retreat to Daily Home Life: EKOUAER Crafts Healing Homewear
From California Retreat to Daily Home Life: EKOUAER Crafts Healing Homewear
Nowadays, many urban women are turning to "healthy retreats" and "daily healing" to alleviate stress. As a result, a set of homewear suitable for long-term relaxation and focused wearing has become a practical necessity. If you're still hesitating about what to wear for a retreat or home-based healing sessions, take a look at EKOUAER homewear, which has recently garnered significant attention in women's retreat circles. Its comfort isn't derived from
Pawmenities Introduces Board and Train Programs at Boston and North Shore Locations
Pawmenities Introduces Board and Train Programs at Boston and North Shore Locati …
Image: https://www.globalnewslines.com/uploads/2026/02/1771004668.jpg BOSTON, MA - Pawmenities, the Boston-based pet care company operating cage-free boarding and daycare facilities in the Seaport District and Lynnfield, has expanded its offerings to include intensive board and train programs at both locations. The programs, which range from one to four weeks, pair professional obedience and behavior training with the residential boarding model the company is known for. The move positions Pawmenities in a growing segment of the
QuasarMD Expands into Full-Body Light Therapy Market with New Recovery Mat
QuasarMD Expands into Full-Body Light Therapy Market with New Recovery Mat
Yorba Linda, California - QuasarMD announced today the launch of its Red Light Therapy Full Body Mat, marking the company's move from localized light therapy devices into the growing full-body wellness category for both consumers and commercial studios. Image: https://www.globalnewslines.com/uploads/2026/02/3590a712d824365182ee8150841b67ba.jpg The new product extends QuasarMD's existing portfolio - which has focused primarily on facial and neck devices - to a single, full-body system designed for use in homes, fitness facilities, and wellness

All 5 Releases